http://orcid.org/0000-0003-0233-893X
About the Authors
- Christian Lienhardt
-
* E-mail: christian.lienhardt@ird.fr
Affiliation Unité Mixte Internationale TransVIHMI, UMI 233 IRD–U1175 INSERM—Université de Montpellier, Institut de Recherche pour le Développement (IRD), Montpellier, France
- Andrew Nunn
-
Affiliation MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College London, London, United Kingdom
- Richard Chaisson
-
Affiliation Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, United States of America
- Andrew A. Vernon
-
Affiliation Division of TB Elimination, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
- Matteo Zignol
-
Affiliation Global TB Programme, World Health Organization, Geneva, Switzerland
- Payam Nahid
-
Affiliation UCSF Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, California, United States of America
- Eric Delaporte
-
Affiliation Unité Mixte Internationale TransVIHMI, UMI 233 IRD–U1175 INSERM—Université de Montpellier, Institut de Recherche pour le Développement (IRD), Montpellier, France
- Tereza Kasaeva
-
Affiliation Global TB Programme, World Health Organization, Geneva, Switzerland
Competing Interests
The authors have declared that no competing interests exist.